Market Access Under Pressure: Pricing, Policy, and Global Pharmaceutical Economics
Day 2 Global Pharma Outlook Stage
07/10/2026 11:55am - 12:20pm
Contributors
Isabell Remus : Global Head of Biosimilars - Sandoz
Global pharmaceutical pricing systems are under unprecedented pressure. US pricing reforms threaten European reference pricing models, while regional markets develop independent approaches to drug access and affordability. This session examines how pricing pressure is reshaping global pharmaceutical economics and what companies are doing to adapt to a fragmented pricing landscape.
- How US pricing reforms cascade through global reference pricing systems.
- Regional approaches to drug pricing and market access in an increasingly fragmented world.
- Strategic responses to pricing pressure and market access challenges across major markets.
